E3 PreliminaryModerate confidencePEM not requiredReview-NarrativePeer-reviewedMachine draft
Standard · 3 min
Irritable bowel syndrome and other functional gastrointestinal disorders.
Şimşek, Ilkay · Journal of clinical gastroenterology · 2011 · DOI
Quick Summary
This review examines irritable bowel syndrome (IBS) and related digestive disorders that cause symptoms like abnormal gut movement and pain sensitivity. The authors found that many people with these conditions also have other illnesses, including ME/CFS and fibromyalgia, suggesting shared underlying causes. Changes in gut bacteria and immune system activity may play an important role in these overlapping conditions.
Why It Matters
This review is important for ME/CFS patients because it formally documents the high prevalence of gastrointestinal comorbidities in ME/CFS and recognizes shared pathogenic mechanisms, particularly immune dysfunction and microbiota alterations. Understanding these overlaps may lead to more integrated clinical assessment and treatment approaches for patients experiencing both ME/CFS and digestive dysfunction.
Observed Findings
Substantial symptom and comorbidity overlap exists between IBS, other FGIDs, and somatic conditions including fibromyalgia and chronic fatigue syndrome
Alterations in intestinal and colonic microflora are present in multiple FGIDs
Evidence of interplay between gut immune cell activity and changes in motility, secretion, and sensation
Cytokine activity and inflammation appear to play important roles in FGID pathogenesis
High prevalence of coexisting gastrointestinal and non-gastrointestinal conditions in affected patients
Inferred Conclusions
Common pathogenic mechanisms, particularly immune dysfunction and microbiota alterations, may underlie the overlap between FGIDs and conditions like ME/CFS and fibromyalgia
Routine assessment for related gastrointestinal and non-gastrointestinal disorders is clinically warranted
Individualized, symptom-guided diagnostic and therapeutic approaches are needed rather than standard protocols
The gut immune system and inflammatory pathways warrant investigation as therapeutic targets across overlapping syndromes
Remaining Questions
What are the specific causal mechanisms linking gut microbiota alterations and immune dysfunction to ME/CFS symptomatology?
What This Study Does Not Prove
This narrative review does not establish causal relationships between gut dysfunction and ME/CFS, nor does it prove that treating gastrointestinal symptoms will improve ME/CFS outcomes. The review is based on synthesizing existing literature rather than presenting new experimental or clinical trial data, so it cannot establish the magnitude or directionality of observed associations.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →